ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Clinical trial NCT05749055 · COMPLETED
Trial details
- NCT number
- NCT05749055
- Sponsor
- Engrail Therapeutics INC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-03
- Primary completion
- 2025-09-18
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.